Judith L. Swain - Apr 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Judith L. Swain
Stock symbol
LXRX
Transactions as of
Apr 28, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 04:30 PM
Previous filing
May 23, 2022
Next filing
May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Award $0 +8.03K $0.00 8.03K Apr 28, 2023 Common Stock 8.03K $0.00 Direct F1, F2
transaction LXRX Stock Option (Right to Buy) Award $0 +12.7K $0.00 12.7K Apr 28, 2023 Common Stock 12.7K $2.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.